MyAverix Finance
AU · Healthcare
Argent Biopharma Ltd (RGT)
Drug Manufacturers - Specialty & Generic
Argent Biopharma Ltd (RGT) is listed on AU in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RGT
Argent Biopharma Ltd (RGT) — FAQ
What is RGT's P/E ratio?
The price-to-earnings (P/E) ratio for Argent Biopharma Ltd (RGT) is 18.00 (data as of 2026-03-23).
Does Argent Biopharma Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Argent Biopharma Ltd (RGT). Check the MyAverix Finance app for the latest dividend data.
What sector is Argent Biopharma Ltd in?
Argent Biopharma Ltd (RGT) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is RGT listed on?
RGT is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.